Cooperative Agreement NU58DP007169

Award Date 6/30/22
Completion Date 6/29/27
Dollars Obligated $9.6M
Awarding Federal Agency
Office of Financial Resources
Federal Grant Program
93.919
Assistance Type
Cooperative Agreement
Place of Performance
Minnesota, USA
Similar Awards
The Fred Hutchinson Cancer Center has been awarded a $9,934,476 Cooperative Agreement from the National Institute on Minority Health and Health Disparities (CFDA 93.307 Minority Health and Health Disparities Research) to implement the "CANOE Partnership: Cancer Awareness, Navigation, Outreach, and Equitable Indigenous Health Outcomes" project. The project aims to improve cancer outcomes for American Indian and Alaska Native (AI/AN) communities through three research initiatives:...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) totals $331,944 and supports research to advance cancer health equity for American Indian and Alaskan Native (AIAN) communities. The key objectives are to: Identify somatic genomic alterations associated with Indigenous American ancestry in Hispanic/Latino gastric cancer samples that may be applicable to AIAN populations. This research will be...
The University of Oklahoma Health Sciences Center was awarded a $7,032,762 Cooperative Agreement from the National Institute on Minority Health and Health Disparities (CFDA 93.307 Minority Health and Health Disparities Research) to establish the Improving Cancer Outcomes in Native American Communities (ICON) U19 Center. The ICON Center aims to conduct research and interventions to address cancer disparities experienced by American Indian and Alaska Native communities in Oklahoma and beyond....
The National Cancer Institute (NCI) awarded a $300,374 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to The University of South Dakota (USD) to develop and test the efficacy of a mobile web app intervention to promote cervical cancer screening among indigenous women in the Yankton Sioux Tribe reservation in South Dakota. The goal of the 4-year project is to increase cervical cancer screening rates among this underserved population, which experiences...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) provides $794,090 to the University of Oklahoma Health Sciences Center to develop and pilot test culturally sensitive digital outreach interventions to increase rates of diagnostic colonoscopy among Native American patients in Oklahoma. The key activities under this 2-year award include: 1) co-developing and integrating mobile health outreach strategies (SMS texts, videos) and...
The Native American Community Clinic (NACC) was awarded a $1,120,220 Cooperative Agreement from the Indian Health Service (IHS) Health Management Development Program (CFDA 93.228) to implement a Hepatitis C, HIV, and Syphilis Syndemic Project. The project aims to expand staffing and care coordination, improve clinical operations and workflow, and strengthen community engagement and outreach to address the intersecting epidemics of HIV, hepatitis C, and syphilis disproportionately impacting the...
The National Cancer Institute (NCI) awarded a $447,686 Cooperative Agreement (CFDA 93.393 - Cancer Cause and Prevention Research) to the Alaska Native Tribal Health Consortium (ANTHC) to establish the first community-engaged cohort study investigating colorectal cancer (CRC) risk factors among Alaska Native people. The 5-year project aims to enroll 1,000 individuals prior to colonoscopy screening in Anchorage and regional tribal hospitals to collect exposome data, medical histories, and...
The Centers for Disease Control and Prevention (CDC) awarded a $2,304,893 five-year Cooperative Agreement (Grant No. NU58DP007934) under the Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health program (CFDA 93.421) to the Albuquerque Area Indian Health Board Inc. (AAIHB), a tribal government and American Indian-owned organization located in Albuquerque, New Mexico. Through this funding, AAIHB will provide public health...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $3,200,000 Cooperative Agreement under the Cooperative Agreements for State-Based Comprehensive Breast and Cervical Cancer Early Detection Programs (CFDA 93.919) to the American Cancer Society, Inc. This 5-year award (8/1/2024 - 7/31/2029) will fund the development of comprehensive breast and cervical cancer early detection programs, with a focus on increasing cancer screening rates, providing technical assistance, supporting...
This Project Grant award of $328,822 from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program will fund the development and evaluation of a mobile health (mHealth) platform called the Integrated Cancer Awareness Network (ICAN). The ICAN platform aims to educate primary care providers and patients in India on cancer risk factors, symptoms, screening tests, and the benefits of early detection. The project will involve creating apps and an...

SUPPORT CANCER CONTROL EFFORTS IN IHS NASHVILLE REGION FOR TRIBAL/URBAN AMERICAN INDIAN AND ALASKA NATIVE COMMUNITIES - THE AMERICAN INDIAN CANCER FOUNDATION (AICAF) SEEKS FUNDING TO CONTINUE IMPLEMENTING SCREEN OUR CIRCLE (NATIONAL BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM) AND INDIGENOUS CANCER SOLUTIONS (COMPREHENSIVE CANCER CONTROL PROGRAM) WITH EFFORTS FOCUSED ON THE INDIAN HEALTH SERVICES (IHS) NASHVILLE REGION. CANCER CONTINUES TO BE THE LEADING CAUSE OF DEATH AMONG AMERICAN INDIANS AND ALASKA NATIVES (AI/AN). AI/ANS IN THE UNITED STATES EXPERIENCE SOME OF THE WORST CANCER OUTCOMES WORLDWIDE. THIS REALITY IS STAGGERING; CONSIDERING CANCER AMONG AI/ANS WAS RARE PRIOR TO THE LAST TWO DECADES. AS CANCER MORTALITY RATES AMONG MOST RACES HAVE BEEN DECREASING DURING THIS TIMEFRAME, AI/ANS ARE NOT EXPERIENCING DECREASED RATES (CDC, 2010). THE NASHVILLE IHS REGION IS HOME TO 36 TRIBAL NATIONS AND SERVICES 32 TRIBAL PROGRAMS AND FOUR URBAN INDIAN HEALTH PROGRAMS (UIHP) LOCATED IN DALLAS, BALTIMORE, BOSTON, AND LONG ISLAND CITY PROVIDING CARE TO 122,000 ACTIVE PATIENTS. HOWEVER, MUCH OF THE DATA FOR THE IHS NASHVILLE AREA IS SUPPRESSED, SUGGESTING LARGER POPULATIONS AND A GREATER NEED FOR CANCER PREVENTION PROGRAMS. AICAF IS REQUESTING SUPPORT TO CONTINUE THE SCREEN OUR CIRCLE (SOC) PROGRAM AND THE INDIGENOUS CANCER SOLUTIONS (ICS) PROGRAM (FORMERLY KNOWN AS URBAN CANCER SOLUTIONS). WHILE OUR EXISTING DP17-1701 PROGRAMS ARE NATIONAL AND FOCUSED ON UIHPS, THIS FUNDING WILL SUPPORT A SPECIFIC REGION WITH HISTORICALLY UNMET NEEDS. THE URBAN INTER-TRIBAL CENTER OF TEXAS, A CURRENT DP17-1701 PARTNER, IS COMMITTED TO THIS NEW FUNDING OPPORTUNITY. ADDITIONALLY, WE HAVE IDENTIFIED TWO OTHER CLINICS IN THIS REGION READY TO PARTNER. THE SOC PROGRAM WILL LEVERAGE DATA AND SURVEILLANCE SYSTEMS, BUILD STRATEGIC PARTNERSHIPS, ELEVATE SCREENING OPPORTUNITIES AND IMPLEMENT EBIS, IN ADDITION TO EVALUATING AND MONITORING ACTIVITIES TO REDUCE CANCER DISPARITIES. AICAF STAFF NOT ONLY COME WITH EDUCATION AND EXPERIENCE IN IMPLEMENTING DP17-1701, OUR STAFF ALSO COME FROM AN INDIGENOUS LENS TO ASSIST IN THE PROMOTION OF HEALTH EQUITY AND AN OVERALL INCREASE IN PREVENTATIVE CANCER SCREENINGS. IN YEAR 1, WE WILL PARTNER WITH TWO CLINICS FOR REIMBURSABLE SERVICES, INCLUDING BREAST AND CERVICAL CANCER SCREENINGS AND PATIENT NAVIGATION, REACHING OVER 300 WOMEN WITH AN OVERALL GOAL TO PARTNER WITH 5 CLINICS BY YEAR 2. OUTCOMES INCLUDE INCREASED PARTNERSHIPS, EXPANDED DATA SOVEREIGNTY OF CLINICS AND COMMUNITIES, AND SUSTAINING EBIS. THE ICS PROGRAM WILL CONTINUE IMPLEMENTING SHARED VISIONS AND PLANS BASED ON DISEASE BURDEN AND SURVEILLANCE DATA, ADJUSTING ITS NATIONAL COALITION TO ALIGN WITH THE NASHVILLE IHS REGION AND REACHING ACHIEVABLE OBJECTIVES THROUGH AN UPDATED CANCER PLAN. THE ICS PROGRAM WILL IMPLEMENT THE FULL SUITE OF STRATEGIES WHILE TAILORING THE ACTIVITIES TO BE CULTURALLY-GROUNDED. THE PROGRAM WILL PARTNER WITH TWO CLINICS IN YEAR 1 AND EXPAND TO TWO MORE IN YEAR 2, FOR A TOTAL OF FOUR CLINIC PARTNERS CONTRACTED TO IMPLEMENT EBIS IN YEARS 2-5. THE PROPOSED OUTCOMES ARE SHARED IN THE ATTACHED APPLICATION, BUT THE LONG TERM OUTCOMES REMAIN IN ALIGNMENT WITH MANY OF AICAF'S CORE GOALS; REDUCE AI/AN CANCER RISK THROUGH PRIMARY PREVENTION; DECREASE AI/AN CANCER BURDEN BY INCREASING SCREENING RATES; INCREASE THE QUALITY OF LIFE AMONG AI/AN CANCER SURVIVORS BY EXPANDING SUPPORT SERVICES; AND ULTIMATELY ELIMINATE THE CANCER BURDENS. AS A NATIVE-LED ORGANIZATION, WE STRIVE TO BE A TRUSTED PARTNER BY TRIBAL AND URBAN COMMUNITY MEMBERS, LEADERS, HEALTH CARE PROVIDERS, AND OTHERS THROUGHOUT THE UNITED STATES. WE OFFER A WEALTH OF EXPERTISE THAT WEAVES TOGETHER THE MOST ROBUST SCIENTIFIC EVIDENCE WITH TRADITIONAL INDIGENOUS WISDOM TO IMPROVE CANCER SCREENING RATES AND SUPPORT HEALTH SYSTEMS CHANGE FOR OUR AI/AN POPULATION. OUR HIGHLY TRAINED, DEDICATED, AND EXPERIENCED TEAM IS READY TO PARTNER TO INCREASE CANCER SCREENING RATES AND ELIMINATE T

Posted 5/26/22, 12:00 AM